the board issues, renews, and disciplines physician licenses statewide
STEP-5 found that lifestyle alone resulted in a -0.6% weight reduction versus -16.7% at 104 weeks
What sets Kureshi Weight Loss & Medspa apart is Dr
Tirzepatide is a once-weekly injectable GLP-1/GIP medication prescribed to support appetite control and weight management
Much of the supporting research summarized in peer-reviewed literature relies on animal studies, such as GLP-1 receptor-knockout mice and rodent injection trials, rather than large-scale human trials, and peptide-based drugs overall are described as rarely used in real-world patient care because of lingering questions about safety, effectiveness, and inadequate insurance coverage
While these effects can vary from person to person and are still being studied, some patients experience positive changes that extend beyond appetite regulation